1. Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells. (March 2021) Authors: Gentilini, A.; Lori, G.; Caligiuri, A.; Raggi, C.; Maira, G. Di; Pastore, M.; Piombanti, B.; Lottini, T.; Arcangeli, A.; Madiai, S.; Taddei, A.; Banales, J.M.; Matteo, S. Di; Alvaro, D.; Andersen, J.B.; Duwe, L.; Tubita, A.; Rovida, E.; Marra, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients. (March 2023) Authors: Lori, G.; Raggi, C.; Piombanti, B.; Pastore, M.; Booijink, R.; Navari, N.; Rovida, E.; Gastaldelli, A.; Andersen, J.; Lewinska, M.; Marra, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fatty acids regulate the biology of cholangiocarcinoma cells. (February 2020) Authors: Lori, G.; Raggi, C.; Booijnk, R.; B, B. Piombanti; Pastore, M.; Rovida, E.; Marra, F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fatty Acids regulate the biology of cholangiocarcinoma cells. (March 2021) Authors: Lori, G.; Raggi, C.; Piombanti, B.; Pastore, M.; Booijnk, R.; Rovida, E.; Andersen, J.B.; Lewinska, M.; Marra, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hepatocyte depletion of ERK5 impairs the response to lipotoxic oxidative stress resulting in defective insulin receptor signaling. (March 2023) Authors: Menconi, A.; Di Maira, G.; Lori, G.; Piombanti, B.; Navari, N.; Taddei, M.L.; Petta, S.; Pipitone, R.; Grimaudo, S.; Campani, C.; Tournier, C.; Rovida, E.; Marra, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hepatocyte expression of the protein kinase ERK5 regulates insulin sensitivity. (February 2019) Authors: Di Maira, G.; Lori, G.; Piombanti, B.; Taddei, M.L.; Parri, M.; Rovida, E.; Chiarugi, P.; Marra, F. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hepatocyte-specific deletion of ERK5 worsens insulin resistance in a murine model of nonalcoholic fatty liver disease (NAFLD). (February 2020) Authors: Di Maira, G.; Lori, G.; Piombanti, B.; Taddei, M.L.; Parri, M.; Chiarugi, P.; Tournier, C.; Rovida, E.; Marra, F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mitochondrial oxidative metabolism contributes to maintain a cancer stem cell phenotype in cholangiocarcinoma. (February 2020) Authors: Raggi, C.; Taddei, M.L.; Sacco, E.; Navari, N.; Correnti, M.; Piombanti, B.; Pastore, M.; Iorio, J.; Lori, G.; Peano, C.; Cibella, J.; Lewinska, M.; Andersen, J.B.; Di Maira, G.; Ramazzotti, M.; Orlandi, Ivan; Chiarugi, P.; Marra, F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P17-29 Development of innovative rodent models to mimic gender-affirming hormone therapies for hazard identification of transgender people: preliminary data. (1st September 2022) Authors: Tassinari, R.; Tammaro, A.; Lori, G.; Martinelli, A.; Cancemi, L.; Frassanito, P.; Montrucchio, F.; Maranghi, F. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver. (February 2020) Authors: Grimaudo, S.; Bartesaghi, S.; Rametta, R.; Marra, F.; Mancina, R.M.; Pihlajamäki, J.; Kakol-Palm, D.; Andréasson, A.C.; Dongiovanni, P.; Fracanzani, A.L.; Lori, G.; Männistö, V.; Pellegrini, G.; Bohlooly-Y, M.; Pennisi, G.; Pipitone, R.M.; Spagnuolo, R.; Craxì, A.; Lindén, D.; Valenti, L. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗